查詢結果分析
相關文獻
- Bacteremia and Fungemia in Patients with Advanced Human Immunodeficiency Virus (HIV) Infection in Taiwan
- Perinatal Candidiasis and Transient Maternal Candidemia: Report of One Case
- Serratia Marcescens Bacteremia: Clinical Features and Antimicrobial Susceptibilities of the Isolates
- Vibrio Parahemolyticus Bacteremia: Case Report
- Porphyromonas Gingivalis Bacteremia and Subhepatic Abscess after Renal Transplantation: A Case Report
- Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features and Antimicrobial Susceptibilities of Isolates
- Nosocomial Gram-Negative Bacteremia in Critically Ill Patients: Epidemiologic Characteristics and Prognostic Factors in 147 Episodes
- Bacteremia in Patients with Hematologic Malignancies
- Bacteremia and Fungemia in Hematological and Oncological Children with Neutropenic Fever:Two-Year Study in a Medical Center
- Acinetobacter Calcoaceticus-Baumannii Complex Bacteremia:Analysis of 82 Cases
頁籤選單縮合
題 名 | Stenotrophomonas Maltophilia Bacteremia in Adults: Four Years' Experience in a Medical Center in Northern Taiwan=成人Stenotrophomonas Maltophilia菌血症:臺灣北部一所醫學中心四年之經驗 |
---|---|
作 者 | 王威勝; 劉昌邦; 李聰明; 黃富源; | 書刊名 | 微免與感染雜誌 |
卷 期 | 37:6 2004.12[民93.12] |
頁 次 | 頁359-365 |
分類號 | 415.27 |
關鍵詞 | 菌血症; Bacteremia; Microbial sensitivity tests; Risk factors; Stenotrophomonas maltophilia; |
語 文 | 英文(English) |
英文摘要 | Stenotrophomonas maltophilia has become an important nosocomial pathogen in immunocompromised patients in Taiwan. Patients with underlying diseases such as diabetes, uremia, and solid malignancy are extremely vulnerable to this organism. S. maltophilia bacteremia has a mortality rate of up to 62% if appropriate antibiotics are not instituted early. Knowledge of the risk factors for infection as well as local susceptibility patterns is helpful in determining which patients should receive empirical antibiotics active against S. maltophilia. This study assessed the characteristics of 50 episodes of S. maltophilia bacteremia in 48 patients admitted between March 3, 1999 and May 21, 2003. The new fluoroquinolone levofloxacin showed promising in vitro activity against S. maltophilia in view of the increasing resistance of isolates to trimethoprim-sulfamethoxazole. For patients at risk for S. maltophilia infection, such as those receiving mechanical ventilation in the ICU or those with multiple vascular access devices, the need for antimicrobial agents to which S. maltophilia is normally sensitive should be considered in selecting empiric therapy. |
本系統中英文摘要資訊取自各篇刊載內容。